# Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model

> **NCT06210542** · — · NOT_YET_RECRUITING · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- ECMO
- Carbapenem-Resistant Enterobacteriaceae Infection

## Interventions

- **DRUG:** ceftazidime avibactam

## Key facts

- **NCT ID:** NCT06210542
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210542, "Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06210542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*